Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Walker

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
Psychiatric Services (Washington, D.C.)|April 22, 2021
Mental Health App Evaluation: Updating the American Psychiatric Association's Framework Through a Stakeholder-Engaged WorkshopSarah Lagan, Margaret R Emerson, Darlene King, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Nephrology (Carlton, Vic.)|April 29, 2024
Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gapBrydee Cashmore, David J Tunnicliffe, Suetonia Palmer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2017
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal ProtectionMarion M Mafham, Natalie Staplin, Jonathan Emberson, et al.
Kidney International Supplements|January 25, 2019
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney diseaseCarol Pollock, Anna Zuk, Hans-Joachim Anders, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Tuberculosis (Edinburgh, Scotland)|February 16, 2013
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCGMichele Tameris, Helen McShane, J Bruce McClain, et al.
Nucleic Acids Research|February 26, 2013
Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studiesAdaikalavan Ramasamy, Daniah Trabzuni, J Raphael Gibbs, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe studyPascal F Durrenberger, Shama Fernando, Samira N Kashefi, et al.
Proceedings. IEEE Global Humanitarian Technology Conference|May 2, 2022
Peer and Non-Peer Academic Scientists and Peer Support Specialist Community of Practice: Stakeholder Engagement to Advance the Science of Peer SupportKaren Fortuna, Mbita Mbao, Arya Kadakia, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
Psychiatric Services (Washington, D.C.)|April 22, 2021
Mental Health App Evaluation: Updating the American Psychiatric Association's Framework Through a Stakeholder-Engaged WorkshopSarah Lagan, Margaret R Emerson, Darlene King, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Nephrology (Carlton, Vic.)|April 29, 2024
Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gapBrydee Cashmore, David J Tunnicliffe, Suetonia Palmer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2017
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal ProtectionMarion M Mafham, Natalie Staplin, Jonathan Emberson, et al.
Kidney International Supplements|January 25, 2019
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney diseaseCarol Pollock, Anna Zuk, Hans-Joachim Anders, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Tuberculosis (Edinburgh, Scotland)|February 16, 2013
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCGMichele Tameris, Helen McShane, J Bruce McClain, et al.
Nucleic Acids Research|February 26, 2013
Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studiesAdaikalavan Ramasamy, Daniah Trabzuni, J Raphael Gibbs, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe studyPascal F Durrenberger, Shama Fernando, Samira N Kashefi, et al.
Proceedings. IEEE Global Humanitarian Technology Conference|May 2, 2022
Peer and Non-Peer Academic Scientists and Peer Support Specialist Community of Practice: Stakeholder Engagement to Advance the Science of Peer SupportKaren Fortuna, Mbita Mbao, Arya Kadakia, et al.
Pageof 31